What are Orally Disintegrating Tablets (ODTs)?

ODTs are pharmaceutical dosage forms that dissolve rapidly in the mouth without the need for water, making them convenient for patients with swallowing difficulties.

How big is the Orally Disintegrating Tablet Market?

The global Orally Disintegrating Tablet Market size was estimated at USD 21.3 Billion in 2023 and is expected to reach USD 49.1 Billion in 2033.

What is the Orally Disintegrating Tablet Market growth?

The global Orally Disintegrating Tablet Market is expected to grow at a compound annual growth rate of 8.7%. From 2024 To 2033

Who are the key companies/players in the Orally Disintegrating Tablet Market?

Some of the key players in the Orally Disintegrating Tablet Markets are AstraZeneca plc., Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bausch Health, GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Bayer AG, Eli Lily and Company, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Other Key Players.

What trends are shaping the ODT Market?

Trends include the use of natural and organic ingredients, personalized medicine, and a focus on technologically advanced products.

What are the challenges faced by the ODT Market?

Challenges include regulatory complexities, manufacturing costs, and the need for specialized equipment.

Global Orally Disintegrating Tablet Market By Drug Class (Anti-Epileptics, Anti-Psychotics, Anti-Hypertensives, Proton Pump Inhibitors, Other Drug Classes) By Disease Indication (CNS Diseases, CVS Disorders, GI Diseases, Other Disease Indications) By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Drug Stores) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 13004
Number of Pages: 304
Format:

- AstraZeneca plc.
- Mylan N.V.
- Pfizer Inc Company Profile
- Johnson & Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Bausch Health
- GlaxoSmithKline plc.
- Sun Pharmaceutical Industries Ltd.
- Bayer AG Company Profile
- Eli Lily and Company
- Dr. Reddys Laboratories Ltd Company Profile
- Takeda Pharmaceutical Company Limited
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 13004
Published Date Jan 2024
Rating
- ★★★★★
  
  ★★★★★
- (26)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)